Multidisciplinary Team Tackles Personalized Medicine for Melanoma Patients with Normal BRAF Gene


A group of melanoma researchers and clinicians have received funding to address an important question in melanoma treatment: are there molecular targets for melanomas that do not harbor a mutation in the BRAF gene? And can we identify drug candidates for these new molecular targets? The Stand Up to Cancer (SUC2) philanthropic program and the Melanoma Research Alliance are jointly funding the 3-year, eight-institution endeavor. Continue reading…


Melanoma Research Alliance – Scientific Retreat Report

“Exciting collaborations are integrating multiple research programs with critical investments and leadership by the Melanoma Research Alliance (MRA), a unique foundation launched by Debra and Leon Black under the auspices of the Milken Institute. MRA’s mission is to accelerate scientific discovery to eliminate death and suffering due to melanoma. Discussions of cutting-edge melanoma research results and clinical care strategies took place on February 27-28, 2013, in Washington, DC, at the MRA’s Fifth Annual Scientific Retreat.”